John T. Schiller

John T. Schiller is a Senior Investigator and NIH Distinguished Investigator at the Laboratory of Cellular Oncology, National Cancer Institute (NCI), NIH. He co-developed the foundational HPV prophylactic vaccines (Cervarix, Gardasil) and leads research on papillomavirus biology, vaccine innovation, and capsid-based cancer therapies. His roles include Deputy Chief of the lab and Head of the Neoplastic Disease Section.

Education:

• B.S. in Molecular Biology, University of Wisconsin-Madison (1975)
• Ph.D. in Microbiology, University of Washington (1982)

Research Focus: Molecular mechanisms of HPV virion assembly and infection, development of prophylactic/therapeutic vaccines, and tumor-targeting HPV capsids. His work leverages VLPs and pseudovirions for translational studies, exploring tissue-resident T cells for STI protection and cancer immunotherapy.

Scientific Awards:

• 2007 Service to America Medal – Federal Employee of the Year
• 2011 Albert Sabin Gold Medal Award
• 2011 AACR-American Cancer Society Award for Research Excellence
• 2014 National Medal of Technology and Innovation
• 2017 ASM Joseph Public Health Award

Team: Collaborates with Staff Scientists (e.g., Nicolas Çuburu, Ph.D.), Senior Associate Scientists (e.g., Patricia M. Day, Ph.D.), and other researchers in the NCI/CCR. The lab focuses on virology, immunology, and clinical applications of HPV-based technologies.